Efficacy and Safety of Thrombolysis for Pediatric Venous Thromboembolism: A Systematic Review and Meta-analysis

Authors

Hassan Kawtharany, University of Kansas Medical Center, Kansas City, Kansas, United States.
Muayad Azzam, University of Kansas Medical Center, Kansas City, Kansas, United States.
Aseel Alkhader, University of Kansas Medical Center, Kansas city, Kansas, United States.
Marisol Betensky, Johns Hopkins All Children's Hospital, St Petersburg, Florida, United States.
Qais Hamarsha, The University of Kansas Medical Center, Kansas City, Kansas, United States.
Hadi K. Abou Zeid, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States.
Razan Mansour, University of Kansas Medical Center, Kansas City, Kansas, United States.
Carine Tabak, University of Kansas School of Medicine, Kansas City, Kansas, United States.
Payal Patel, Emory University, Atlanta, Georgia, United States.
Sarah L. Baghdadi, University of Kansas School of Medicine, Kansas city, Kansas, United States.
Rachel Sara Bercovitz, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States.
Rukhmi Bhat, Ann and Robert H. Lurie Childrens Hospital of Chicago, Chicago, Illinois, United States.
Tina T. Biss, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Brian R. Branchford, Versiti Blood Research Institute, Wauwatosa, Wisconsin, United States.
Leonardo R. Brandão, The Hospital for Sick Children, Toronto, Ontario, Canada.
Anthony Kc Chan, McMaster University, Hamilton, Canada.
E Vincent Faustino, Yale School of Medicine, New Haven, Connecticut, United States.
Julie Jaffray, Rady Children's Hospital, University of California, San Diego, San Diego, California, United States.
Sophie E. Jones, The University of Melbourne, Melbourne, Australia.
Bryce A. Kerlin, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States.
Nicole Kucine, Weill Cornell Medicine, New York, New York, United States.
Riten Kumar, Harvard Medical School, Boston, Massachusetts, United States.
Christoph Male, Medical University of Vienna, Vienna, Austria.
Marie-Claude Pelland-Marcotte, Centre Hospitalier Universitaire de Québec, Quebec City, Quebec, Canada.
Leslie Raffini, Children's Hospital of Philadelphia, Swarthmore, Pennsylvania, United States.
Chittalsinh M. Raulji, University of Nebraska Medical Center / Children's Nebraska, Omaha, Nebraska, United States.
Sarah E. Sartain, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, United States.
Clifford M. Takemoto, St. Jude Children's Hospital, Memphis, Tennessee, United States.
Maria Velez, LSU Health Sciences Center - New OrleansFollow
et al.

Document Type

Article

Publication Date

6-25-2025

Publication Title

Blood advances

Abstract

We conducted this systematic review to evaluate outcomes of thrombolysis followed by anticoagulation versus anticoagulation alone in pediatric patients with venous thromboembolism (VTE). This systematic review addresses mortality, VTE resolution, recurrence, bleeding, and organ-specific outcomes in five population, intervention, comparison, outcomes (PICO) questions on thrombolysis across pulmonary embolism (PE), extremity deep vein thrombosis (DVT), right atrial thrombosis (RAT), cerebral sinus venous thrombosis (CSVT), and renal vein thrombosis (RVT). Meta-analysis reported risk ratios or differences (95% confidence intervals), and absolute effects per 1,000 patients. Certainty of evidence was assessed using GRADE. Thirteen non-randomized studies of intervention were included. No questions were addressed by randomized controlled trials. Thrombolysis might be associated with a higher major bleeding risk, clinically relevant non-major bleeding, or unspecified bleeding events with risk differences of 0.09 (-0.06, 0.23), 0.06 (-0.11, 0.22), and 0.09 (-0.04, 0.23), respectively. In PE with hemodynamic compromise, thrombolysis might be associated with a lower risk of mortality but conclusions on PE progression were uncertain in sub-massive PE. In DVT, thrombolysis may have little to no effect on mortality or thrombus resolution but might be associated with lower risk of post-thrombotic syndrome. In RAT, thrombolysis might have little to no effect on thrombus resolution but a higher risk of major bleeding and mortality. For CSVT and RVT, the evidence was very limited. These findings were based on very low-certainty evidence due to confounding and imprecision from small sample sizes. This systematic review highlights key challenges in developing recommendations for thrombolysis in children with VTE.

PubMed ID

40561511

Share

COinS